乌鸦传媒

Oncology/Hematology

<乌鸦传媒 class='mpt-top_cat_title_description'>News, opinions and meeting coverage in oncology/hematology.

SABCS over a photo of Henry B. Gonzalez Convention Center in San Antonio, TX.

<乌鸦传媒>Palbociclib Regimen Yields 'Incredible' PFS Gain in Metastatic Breast Cancer

Study results are "historic," expert says

SABCS over a photo of Henry B. Gonzalez Convention Center in San Antonio, TX.

<乌鸦传媒>Risk-Reducing Surgery May Benefit BRCA Carriers With Early-Onset Breast Cancer

Lower rates of mortality and cancer recurrence with mastectomy, salpingo-oophorectomy

SABCS over a photo of Henry B. Gonzalez Convention Center in San Antonio, TX.

<乌鸦传媒>Skip Surgery for DCIS in Favor of Active Monitoring?

No invasive cancer increase at 2 years, but editorialists say data don't back active monitoring

A computer rendering of a heart and pulse.

<乌鸦传媒>Lung Cancer Drug Osimertinib Tied to Cardiac Events, Even in Low-Risk Patients

Signal largely driven by newly emerging arrhythmias

A photo of a male physician showing his male patient a tablet.

Industry Clinic 鈥� Ad Insights

<乌鸦传媒>Subcutaneous Cancer Immunotherapies Provide New Options for Physicians and Patients

ASH over a photo of San Diego Convention Center

<乌鸦传媒>Pulled Myeloma Drug Improves Survival in Trial

DREAMM-7 findings help pave the way for Blenrep's return

SABCS over a photo of Henry B. Gonzalez Convention Center in San Antonio, TX.

<乌鸦传媒>Oral SERD Impresses in Advanced Breast Cancer With ESR1 Mutations

However, imlunestrant failed to improve PFS among entire trial population

ASH over a photo of San Diego Convention Center

<乌鸦传媒>One CAR T-Cell Therapy for Multiple Myeloma Tops Another in Propensity Matched Study

Higher response rate, PFS, OS with cilta-cel, but ide-cel had lower rate of severe toxicity

ASHP over a photo of Ernest N. Morial Convention Center in New Orleans, LA.

<乌鸦传媒>Cancer Patients Who Completed Medication Survey Received More Help From Pharmacists

Study assessed pharmacist interventions for adverse events

ASH over a photo of San Diego Convention Center

<乌鸦传媒>Pirtobrutinib Delays Progression in CLL Already Treated With a BTK Inhibitor

But no overall survival benefit seen in confirmatory trial

ASH over a photo of San Diego Convention Center

<乌鸦传媒>Tafasitamab-Based Combination Boosts PFS in Relapsed/Refractory Follicular Lymphoma

Benefit seen in all prespecified subgroups, including high-risk patients

A photo of a female gynecologist putting a cervical brush into a sample container with a female patient in the background.

<乌鸦传媒>USPSTF Plans Changes to Cervical Cancer Screening Recommendations

Self-collected HPV testing is a new addition

A photo of a nurse holding a bag of red blood cells.

<乌鸦传媒>Generous Blood Transfusions Not Beneficial for Some With Burst Brain Aneurysms

SAHARA rounds out this year's notable trials on blood transfusions in critically ill patients

ASH over a photo of San Diego Convention Center

<乌鸦传媒>Benefits of Transplant for Pediatric Sickle Cell Disease Add Up a Decade Later

Better disease outcomes, measures of cognition, and quality-of-life vs standard care, study finds

ASH over a photo of San Diego Convention Center

<乌鸦传媒>Transplantation Fails to Improve Survival in Mantle Cell Lymphoma

New standard of care for patients in first remission?

ASH over a photo of San Diego Convention Center

<乌鸦传媒>Lentiviral Gene Therapy Shows Promise in Severe Hemophilia A

Increased factor VIII levels to mild or moderate range, with annualized bleeding rate of zero

2024 YEAR IN REVIEW CLL over a computer rendering of CAR T cell therapy in chronic lymphocytic leukemia.

<乌鸦传媒>Year in Review: Chronic Lymphocytic Leukemia

Top news in 2024 included the first CAR-T approval for CLL, triplet regimens, and more

A photo of a female physician at her desk talking to her male patient.

Industry Clinic 鈥� Ad Insights

<乌鸦传媒>Alecensa (alectinib) Offers Hope for Certain Patients With ALK Positive NSCLC

ASH over a photo of San Diego Convention Center

<乌鸦传媒>Hydroxyurea Shows Some Benefits in Milder Sickle Cell Disease

Treatment tied to fewer vaso-occlusive pain events, hospitalizations versus placebo

ASH over a photo of San Diego Convention Center

<乌鸦传媒>Fixed-Duration Oral Doublet for Fit CLL Wins in Frontline Setting

AMPLIFY trial paves the way for FDA approval of acalabrutinib plus venetoclax

ASH over a photo of San Diego Convention Center

<乌鸦传媒>Treatment of Smoldering Myeloma Cuts Progression Rate in Half

Daratumumab significantly improved PFS, OS, but identity of high-risk population remains elusive

ASH over a photo of San Diego Convention Center

<乌鸦传媒>Promising Results With Epcoritamab Monotherapy in Relapsed/Refractory CLL

Complete responses seen in 43% of patients in expansion cohort of EPCORE CLL-1 study

ASH over a photo of San Diego Convention Center

<乌鸦传媒>Novel BTK Inhibitor Succeeds in Heavily Pretreated Immune Thrombocytopenia

Rilzabrutinib specifically designed to reduce platelet-targeting autoantibodies

ASH over a photo of San Diego Convention Center

<乌鸦传媒>Loncastuximab-Rituximab Boosts Response Rates in R/R Follicular Lymphoma

Two-thirds of phase II patients had a complete response at 12 weeks of treatment

ASH over a photo of San Diego Convention Center

<乌鸦传媒>Dietary Intervention Shows Promise in Blood Cancers

High-fiber diets tied to improved outcomes in stem-cell transplants, slowing myeloma precursors

<乌鸦传媒>Texting to Improve Adherence to CVD Medications; Detecting Maternal Cancers

Also in TTHealthWatch: U.S. drug prices under Medicare's price negotiation system

ASH over a photo of the San Diego Convention Center

<乌鸦传媒>Dual Targeted CAR-T Yields 99% Response Rate in Pediatric ALL

Cytokine release syndrome developed in all patients, including grade 3/4 events in nearly half

ASH over a photo of San Diego Convention Center

<乌鸦传媒>New Standard for Newly Diagnosed Pediatric B-Cell Acute Lymphoblastic Leukemia

Blinatumomab consolidation reduced risk of relapse by 61% versus chemotherapy alone

ASH over a photo of San Diego Convention Center

<乌鸦传媒>Eltrombopag Improves Outcomes in Kids With Newly Diagnosed ITP

Drug may potentially "transform" approach to upfront treatment, investigator says

A screenshot of Senator Jeff Merkley speaking during this hearing.

<乌鸦传媒>Experts Wrestle Over Uses of PFAS During Senate Hearing

Industry witness warns of unintended consequences of blanket bans

RSNA over a photo of McCormick Place in Chicago, IL.

<乌鸦传媒>Self-Pay, AI-Enhanced Breast Cancer Screening Detected More Cancers

Overall cancer detection rate was about 43% higher versus women who chose not to participate

Onco Break over a computer rendering of a cancer cell.

<乌鸦传媒>AI Breath Test IDs Cancers; More Grief for Prior Auth; Imatinib Discoverer Resigns

News, features, and commentary about cancer-related issues

A photo of a stethoscope in the center of a circle of variously colored cancer ribbons.

<乌鸦传媒>Nearly 6 Million Deaths From Five Major Cancer Types Averted Since 1975

Prevention and screening efforts accounted for 80% of those averted deaths

FDA APPROVED durvalumab (Imfinzi) over a computer rendering of lung cancer.

<乌鸦传媒>Durvalumab Wins FDA Approval in Limited-Stage SCLC

Unprecedented 22.5-month improvement in median overall survival as consolidation therapy

FDA APPROVED zenocutuzumab-zbco (Bizengri) over a computer rendering of monoclonal antibodies attacking cancer cells.

<乌鸦传媒>FDA OKs First Drug Targeting NRG1 Gene Fusion in Pancreatic, Lung Cancers

Zenocutuzumab achieved response rates of 40% in pancreatic adenocarcinoma, 33% in advanced NSCLC

A computer rendering of cell free nucleic acids in the blood.

<乌鸦传媒>Prenatal Cell-Free DNA Sequencing May Help Detect Cancer in Mothers

Nearly half of women with unusual or nonreportable cfDNA-sequencing results had cancer

A computer rendering of a transparent female body with a fatty liver highlighted.

<乌鸦传媒>Serious Outcomes of Steatotic Liver Disease Hit Men and Women Differently

Liver cancer risk higher among men, while cirrhosis more common in women

A computer rendering of sickle cells in the blood flow.

<乌鸦传媒>Makers of Sickle Cell Disease Gene Therapy to Participate in Payment Model, CMS Says

Outcomes-based model designed to improve access to pricey treatments

A photo of a technician putting a human brain into a container of formaldehyde.

<乌鸦传媒>Formaldehyde Causes More Cancer Than Any Other Toxic Air Pollutant

Little is being done to curb the risk

A computer rendering of a transparent body with a tumor in the lungs highlighted.

Industry Clinic 鈥� Ad Insights

<乌鸦传媒>What Could This Exploratory 5-Year Survival Data in Adjuvant NSCLC Treatment Mean?

1

鈥�